Aigen Investment Management, LP Horizon Therapeutics Public LTD CO Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$79.4 - $116.36 $1.25 Million - $1.83 Million	-15,739 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$86.42 - $109.81 $1.36 Million - $1.73 Million	15,739 New	15,739 $1.66 Million
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $180,956 - $220,154	-1,836 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $168,746 - $202,639	1,836 New	1,836 $201,000
Q1 2020 May 08, 2020	SELL	$24.87 - $38.56 $845 - $1,311	-34 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$25.43 - $36.67 $864 - $1,246	34 New	34 $1,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.